JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB92319

Anti-Podoplanin antibody [8.1.1]

Be the first to review this product! Submit a review

|

(9 Publications)

Syrian hamster Monoclonal Podoplanin antibody. Suitable for IHC-Fr and reacts with Mouse samples. Cited in 9 publications.

View Alternative Names

Gp38, Ots8, Pdpn, Podoplanin, Glycoprotein 38, OTS-8, PA2.26 antigen, Transmembrane glycoprotein E11, E11

1 Images
Immunohistochemistry (Frozen sections) - Anti-Podoplanin antibody [8.1.1] (AB92319)
  • IHC-Fr

Unknown

Immunohistochemistry (Frozen sections) - Anti-Podoplanin antibody [8.1.1] (AB92319)

Frozen section (7.5 micron) of murine kidney were incubated with ab92319 antibody at 1ug/ml and detected with an Alexa Fluor®488-conjugated Goat anti-hamster IgG polyclonal used at 1 : 1000 dilution. Exposure time 500 ms.

Key facts

Host species

Syrian hamster

Clonality

Monoclonal

Clone number

8.1.1

Isotype

IgG1

Carrier free

No

Reacts with

Mouse

Applications

IHC-Fr

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

This antibody is designed to detect podoplanin, which is also referred to as gp38 (mouse and rat) and gp36 (human).

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCFr" : {"fullname" : "Immunohistochemistry (Frozen sections)", "shortname":"IHC-Fr"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "IHCFr-species-checked": "testedAndGuaranteed", "IHCFr-species-dilution-info": "0.5-1 µg/mL", "IHCFr-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein G
Storage buffer
Preservative: 0.1% Sodium azide Constituents: PBS
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Podoplanin also known as gp36 and PDPN is a small transmembrane protein weighing approximately 36 kDa. It mainly expresses in lymphatic endothelial cells podocytes and various other tissues like the lung and kidney. It functions as a marker in mesothelial cells and is noticeable in histochemical studies such as mesothelioma using podoplanin staining in immunohistochemistry (IHC). Podoplanin emerges as an important tool in identifying lymphatic vessels and has significant roles in the development of certain tissues.
Biological function summary

The protein participates in maintaining the integrity of cell structures and lymphangiogenesis. This protein does not form part of a larger complex but actively interacts with different molecules. In lymphoid tissues podoplanin contributes to the proper formation of lymphatic channels and assists in platelet aggregation. These actions are pivotal in wound healing and protecting the epithelial cell layers in multiple organs.

Pathways

Podoplanin impacts the platelet activation pathway and the Lymphatic Vessel Development pathway. Its interaction with CLEC-2 (C-type lectin-like receptor 2) triggers downstream signaling leading to changes in platelet morphology and actin cytoskeleton reorganization. Podoplanin’s activation of these pathways links it to key processes that include cell migration and tissue homeostasis TGF-beta interaction also represents a significant relationship within these pathways.

Podoplanin has correlations with conditions like cancer specifically mesothelioma and squamous cell carcinoma. Dysregulation of podoplanin and its pathways may contribute to tumor progression and metastasis. In mesothelioma podoplanin interacts with other proteins like E-cadherin influencing cancer cell migration and adhesion. Its role in disease states highlights the importance of podoplanin IHC as a diagnostic tool aiding in the better understanding and identification of disease pathology.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Mediates effects on cell migration and adhesion through its different partners. During development plays a role in blood and lymphatic vessels separation by binding CLEC1B, triggering CLEC1B activation in platelets and leading to platelet activation and/or aggregation (PubMed : 14522983, PubMed : 15231832, PubMed : 17616532, PubMed : 20110424). Interaction with CD9, on the contrary, attenuates platelet aggregation and pulmonary metastasis induced by PDPN. Mediates effects on cell migration and adhesion through its different partners. Through MSN or EZR interaction promotes epithelial-mesenchymal transition (EMT) leading to ERZ phosphorylation and triggering RHOA activation leading to cell migration increase and invasiveness. Interaction with CD44 promotes directional cell migration in epithelial and tumor cells (By similarity). In lymph nodes (LNs), controls fibroblastic reticular cells (FRCs) adhesion to the extracellular matrix (ECM) and contraction of the actomyosin by maintaining ERM proteins (EZR; MSN and RDX) and MYL9 activation through association with unknown transmembrane proteins. Engagement of CLEC1B by PDPN promotes FRCs relaxation by blocking lateral membrane interactions leading to reduction of ERM proteins (EZR; MSN and RDX) and MYL9 activation (PubMed : 25347465). Through binding with LGALS8 may participate in connection of the lymphatic endothelium to the surrounding extracellular matrix (By similarity). In keratinocytes, induces changes in cell morphology showing an elongated shape, numerous membrane protrusions, major reorganization of the actin cytoskeleton, increased motility and decreased cell adhesion (PubMed : 10574709). Controls invadopodia stability and maturation leading to efficient degradation of the extracellular matrix (ECM) in tumor cells through modulation of RHOC activity in order to activate ROCK1/ROCK2 and LIMK1/LIMK2 and inactivation of CFL1 (By similarity). Required for normal lung cell proliferation and alveolus formation at birth (PubMed : 12654292). Does not function as a water channel or as a regulator of aquaporin-type water channels (By similarity). Does not have any effect on folic acid or amino acid transport (PubMed : 12032185).
See full target information Pdpn

Publications (9)

Recent publications for all applications. Explore the full list and refine your search

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 39:e70272 PubMed39777689

2025

The C3/C3aR pathway exacerbates acetaminophen-induced mouse liver injury via upregulating podoplanin on the macrophage.

Applications

Unspecified application

Species

Unspecified reactive species

Zhanli Xie,Jiang Jiang,Fei Yang,Jingjing Han,Zhenni Ma,Tao Wen,Xia Bai

Molecular therapy. Nucleic acids 35:102121 PubMed38333673

2024

Topical tissue nanotransfection of is effective in the prophylactic management of lymphedema.

Applications

Unspecified application

Species

Unspecified reactive species

Ganesh Mohan,Imran Khan,Colby R Neumann,Miguel D Jorge,Shahnur Ahmed,Luci Hulsman,Mithun Sinha,Gayle M Gordillo,Chandan K Sen,Aladdin H Hassanein

eLife 11: PubMed36107485

2022

Neutrophil-mediated fibroblast-tumor cell il-6/stat-3 signaling underlies the association between neutrophil-to-lymphocyte ratio dynamics and chemotherapy response in localized pancreatic cancer: A hybrid clinical-preclinical study.

Applications

Unspecified application

Species

Unspecified reactive species

Iago de Castro Silva,Anna Bianchi,Nilesh U Deshpande,Prateek Sharma,Siddharth Mehra,Vanessa Tonin Garrido,Shannon Jacqueline Saigh,Jonathan England,Peter Joel Hosein,Deukwoo Kwon,Nipun B Merchant,Jashodeep Datta

Nature communications 12:3460 PubMed34103491

2021

Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema.

Applications

Unspecified application

Species

Unspecified reactive species

Dániel Szőke,Gábor Kovács,Éva Kemecsei,László Bálint,Kitti Szoták-Ajtay,Petra Aradi,Andrea Styevkóné Dinnyés,Barbara L Mui,Ying K Tam,Thomas D Madden,Katalin Karikó,Raghu P Kataru,Michael J Hope,Drew Weissman,Babak J Mehrara,Norbert Pardi,Zoltán Jakus

Frontiers in immunology 10:3043 PubMed31993056

2020

Lymph Flow Induces the Postnatal Formation of Mature and Functional Meningeal Lymphatic Vessels.

Applications

Unspecified application

Species

Unspecified reactive species

László Bálint,Zsombor Ocskay,Bálint András Deák,Petra Aradi,Zoltán Jakus

Nature communications 10:3415 PubMed31363095

2019

Standard screening methods underreport AAV-mediated transduction and gene editing.

Applications

Unspecified application

Species

Unspecified reactive species

Jonathan F Lang,Sushila A Toulmin,Kasey L Brida,Laurence C Eisenlohr,Beverly L Davidson

Cell stem cell 8:639-48 PubMed21624809

2011

Notch-dependent differentiation of adult airway basal stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Jason R Rock,Xia Gao,Yan Xue,Scott H Randell,Young-Yun Kong,Brigid L M Hogan

The Journal of experimental medicine 176:1477-82 PubMed1402691

1992

Characterization and cloning of a novel glycoprotein expressed by stromal cells in T-dependent areas of peripheral lymphoid tissues.

Applications

Unspecified application

Species

Unspecified reactive species

A G Farr,M L Berry,A Kim,A J Nelson,M P Welch,A Aruffo

The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 40:651-64 PubMed1374092

1992

Characterization of an antigenic determinant preferentially expressed by type I epithelial cells in the murine thymus.

Applications

Unspecified application

Species

Unspecified reactive species

A Farr,A Nelson,S Hosier
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com